Latest News & Features
Americas
Astellas Pharma, Medivation and the regents of the University of California have collectively sued Actavis for alleged patent infringement over Xtandi, a treatment for prostate cancer. 6 December 2016
Americas
Anyone seeking a deal with a life sciences company must understand the value and potential risks of its IP, as Karen Mangasarian and Ryan Murphey of Ropes & Gray explain. 6 December 2016
Americas
Oral arguments in Life Technologies v Promega are due to take place tomorrow in the US Supreme Court to determine whether the US Court of Appeals for the Federal Circuit correctly defined “substantial portion”. 5 December 2016
Americas
The US Court of Appeals for the Federal Circuit has affirmed rulings in a patent dispute which saw Leica Biosystems Melbourne Party succeed in two inter partes re-examinations against patents belonging to Dako Denmark. 5 December 2016
Americas
Forest Laboratories, Allergan and Ironwood Pharmaceuticals have filed a complaint against Teva, Mylan, Sandoz and Aurobindo for alleged patent infringement. 2 December 2016
article
Pharmaceutical company Mallinckrodt has filed a complaint against Mylan for alleged patent infringement over its drug Ofirmev, a treatment for fever. 2 December 2016
Americas
Merck has filed a complaint against Strides Pharma for alleged patent infringement over Sustiva, an antiviral medication that prevents HIV from multiplying in the human body. 1 December 2016
Americas
An interference proceeding on the patent rights to CRISPR/Cas9 will take place on December 6, with the judges setting the definition of the disputed invention as “the use of CRISPR in a method in a eukaryotic cell”. 1 December 2016
Europe
Law firm HGF has hired a new patent director, Martin Connors, who will start tomorrow. 30 November 2016
Americas
A US district court has dismissed a patent infringement lawsuit between US-based biotechnology company Genzyme and Mylan Pharmaceuticals after the companies agreed to settle. 30 November 2016